VIDO vaccines for newborns funded by the Bill & Melinda Gates Foundation

Saskatoon, SK - June 27, 2005 - Today the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) was awarded $6.9 million (Can.) to develop and improve vaccines for newborns through the Grand Challenges in Global Health competition, an initiative supported by the Bill and Melinda Gates Foundation and other partners.

Competing with approximately 1,500 teams from 75 countries, VIDO - one of three Canadian grant recipients - has secured funding for five years to develop technologies to make existing and new vaccines suitable for delivery to newborns. VIDO's internationally recognized team includes researchers from U of S, the University of British Columbia, Dalhousie University, and the International Vaccine Institute (Korea).

The Canadian Institutes of Health Research (CIHR) release

The Bill & Melinda Gates Foundation release

VIDO web feature